Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Global Forecast 2025-2030- Product Image

Sale

Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Global Forecast 2025-2030

Report
185 Pages
October 2024
Region: Global
360iResearch™
ID: 5925159

UP TO €664EUR$697USD£553GBP OFF until Dec 31^st 2024

The Next-Generation Breast Cancer Diagnostic & Screening Market grew from USD 22.81 billion in 2023 to USD 25.12 billion in 2024. It is expected to continue growing at a CAGR of 10.91%, reaching USD 47.11 billion by 2030.

The market for next-generation breast cancer diagnostics and screening is witnessing significant evolution, driven by the need for more precise, rapid, and non-invasive methods. This encompasses advanced genomic and proteomic technologies, AI-enabled imaging solutions, and liquid biopsy techniques that deliver greater accuracy and early detection capabilities. The necessity for improved diagnostic modalities stems from the rising incidence of breast cancer globally and the consequent demand for better patient outcomes and personalized treatment plans. The application primarily spans hospitals, diagnostic laboratories, and specialty clinics, while the end-use scope varies from early diagnostic screenings and advanced-stage diagnostics to treatment monitoring. Key growth factors include increasing awareness about breast cancer, technological advancements, and favorable government initiatives supporting cancer research. Opportunities lie in untapped markets across emerging economies and the potential for integrating AI and machine learning with traditional screening methods to enhance accuracy and reduce false positives. As recommendations, stakeholders should focus on partnerships for technology sharing and develop cost-effective solutions tailored for low-income regions. However, challenges such as high costs of advanced diagnostic equipment, regulatory complexities, and issues concerning data privacy and patient consent can impede growth. Moreover, limitations like technical expertise shortage required for new technologies further constrain market expansion. Innovation could be directed towards developing affordable devices with minimal infrastructural requirements and exploring new biomarkers for early detection. Emphasizing non-invasive methods can tremendously benefit patient compliance and market penetration. The nature of the market is characterized by rapid technological progress, competitive rivalry, and stringent regulations, necessitating continuous innovation and strategic collaborations. Robust R&D and investment in AI integration within diagnostics are critical for firms aiming to capitalize on future growth potential and to maintain competitive advantage in this dynamic market landscape.

Understanding Market Dynamics in the Next-Generation Breast Cancer Diagnostic & Screening Market

The Next-Generation Breast Cancer Diagnostic & Screening Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising prevalence of breast cancer worldwide
- Growing inclination towards early diagnosis and treatment of diseases
- Government initiatives to raise awareness regarding breast cancer
Market Restraints
- Expensive breast cancer diagnostic & screening technologies
Market Opportunities
- Advancements in next-generation breast cancer diagnostic & screening technologies
- Strategic alliances and investments to manufacture innovative breast cancer diagnostic solutions
Market Challenges
- Complexity in manufacturing and stringent regulatory approval process

Exploring Porter’s Five Forces for the Next-Generation Breast Cancer Diagnostic & Screening Market

Porter’s Five Forces framework further strengthens the insights of the Next-Generation Breast Cancer Diagnostic & Screening Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Next-Generation Breast Cancer Diagnostic & Screening Market

External macro-environmental factors deeply influence the performance of the Next-Generation Breast Cancer Diagnostic & Screening Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Next-Generation Breast Cancer Diagnostic & Screening Market

The Next-Generation Breast Cancer Diagnostic & Screening Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Next-Generation Breast Cancer Diagnostic & Screening Market

The Next-Generation Breast Cancer Diagnostic & Screening Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Next-Generation Breast Cancer Diagnostic & Screening Market

The Next-Generation Breast Cancer Diagnostic & Screening Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation Breast Cancer Diagnostic & Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agendia Inc., Agilent Technologies, Inc., ARTIVION INC., Becton, Dickinson and Company, Benitec Biopharma Ltd, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Centogene N.V., Danaher Corporation, Epic Sciences, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Hologic, Inc., Illumina, Inc., Invivoscribe, Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Merck & Co., Inc., Myriad Genetics, Inc., Novartis AG, Pfizer Inc., QIAGEN N.V., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Next-Generation Breast Cancer Diagnostic & Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Accessories
- Breast Imaging Systems
- Software & Services
Diagnostic Technology
- DNA Microarrays
- Lab-on-a-Chip & Reverse Transcriptase-PCR
- Molecular Diagnostics
- Next Generation Sequencing
- Protein Microarrays
- qPCR & Multiplexing
Screening Technology
- Ionizing Breast Imaging Technologies
  - 3D Breast Tomosynthesis
  - Analog Mammography
  - Cone-Beam Computed Tomography (CBCT)
  - Contrast-Enhanced Mammography (CEM)
  - Full-Field Digital Mammography (FFDM)
  - Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI)
  - Positron Emission Mammography (PEM)
  - Positron Emission Tomography and Computed Tomography (PET-CT)
- Non-ionizing Breast Imaging Technologies
  - Automated Whole-Breast Ultrasound (AWBU)
  - Breast MRI
  - Breast Thermography
  - Breast Ultrasound
  - Electric Impedance Tomography
  - Optical Imaging
Application
- Cancer Screening
- Companion Diagnostics
- Risk Analysis
- Therapeutic Monitoring
End User
- Breast Care Centers
- Diagnostic Imaging Centers
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of breast cancer worldwide
5.1.1.2. Growing inclination towards early diagnosis and treatment of diseases
5.1.1.3. Government initiatives to raise awareness regarding breast cancer
5.1.2. Restraints
5.1.2.1. Expensive breast cancer diagnostic & screening technologies
5.1.3. Opportunities
5.1.3.1. Advancements in next-generation breast cancer diagnostic & screening technologies
5.1.3.2. Strategic alliances and investments to manufacture innovative breast cancer diagnostic solutions
5.1.4. Challenges
5.1.4.1. Complexity in manufacturing and stringent regulatory approval process
5.2. Market Segmentation Analysis
5.2.1. Product: Need for advanced breast imaging systems for enhanced clinical outcomes
5.2.2. End User: Expanding use of breast cancer diagnostics in hospitals to cater to a wider patient population
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Next-Generation Breast Cancer Diagnostic & Screening Market, by Product

6.1. Introduction
6.2. Accessories
6.3. Breast Imaging Systems
6.4. Software & Services

7. Next-Generation Breast Cancer Diagnostic & Screening Market, by Diagnostic Technology

7.1. Introduction
7.2. DNA Microarrays
7.3. Lab-on-a-Chip & Reverse Transcriptase-PCR
7.4. Molecular Diagnostics
7.5. Next Generation Sequencing
7.6. Protein Microarrays
7.7. qPCR & Multiplexing

8. Next-Generation Breast Cancer Diagnostic & Screening Market, by Screening Technology

8.1. Introduction
8.2. Ionizing Breast Imaging Technologies
8.2.1. 3D Breast Tomosynthesis
8.2.2. Analog Mammography
8.2.3. Cone-Beam Computed Tomography (CBCT)
8.2.4. Contrast-Enhanced Mammography (CEM)
8.2.5. Full-Field Digital Mammography (FFDM)
8.2.6. Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI)
8.2.7. Positron Emission Mammography (PEM)
8.2.8. Positron Emission Tomography and Computed Tomography (PET-CT)
8.3. Non-ionizing Breast Imaging Technologies
8.3.1. Automated Whole-Breast Ultrasound (AWBU)
8.3.2. Breast MRI
8.3.3. Breast Thermography
8.3.4. Breast Ultrasound
8.3.5. Electric Impedance Tomography
8.3.6. Optical Imaging

9. Next-Generation Breast Cancer Diagnostic & Screening Market, by Application

9.1. Introduction
9.2. Cancer Screening
9.3. Companion Diagnostics
9.4. Risk Analysis
9.5. Therapeutic Monitoring

10. Next-Generation Breast Cancer Diagnostic & Screening Market, by End User

10.1. Introduction
10.2. Breast Care Centers
10.3. Diagnostic Imaging Centers
10.4. Hospitals & Clinics

11. Americas Next-Generation Breast Cancer Diagnostic & Screening Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Next-Generation Breast Cancer Diagnostic & Screening Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Next-Generation Breast Cancer Diagnostic & Screening Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. GE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection
14.3.2. Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations
14.3.3. Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next Generation Sequencing-Based Testing for Cancer Patients in International Markets
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET RESEARCH PROCESS
FIGURE 2. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET DYNAMICS
TABLE 7. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DNA MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY LAB-ON-A-CHIP & REVERSE TRANSCRIPTASE-PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY QPCR & MULTIPLEXING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY 3D BREAST TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY CONE-BEAM COMPUTED TOMOGRAPHY (CBCT), BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY CONTRAST-ENHANCED MAMMOGRAPHY (CEM), BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY FULL-FIELD DIGITAL MAMMOGRAPHY (FFDM), BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING/BREAST SPECIFIC GAMMA IMAGING (MBI/BSGI), BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY POSITRON EMISSION MAMMOGRAPHY (PEM), BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT), BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU), BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST THERMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ELECTRIC IMPEDANCE TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY RISK ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 72. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 73. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 79. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 80. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 109. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 110. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 116. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 117. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 130. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 131. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 165. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 166. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 172. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 173. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 179. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 180. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 190. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 194. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 195. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 201. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 202. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 208. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 209. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 215. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 216. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 222. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 223. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 236. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 237. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 20

Companies Mentioned

The leading players in the Next-Generation Breast Cancer Diagnostic & Screening market, which are profiled in this report, include:

Abbott Laboratories
Agendia Inc.
Agilent Technologies, Inc.
ARTIVION INC.
Becton, Dickinson and Company
Benitec Biopharma Ltd
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Centogene N.V.
Danaher Corporation
Epic Sciences, Inc.
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd.
Fujifilm Holdings Corporation
GE HealthCare Technologies, Inc.
Hologic, Inc.
Illumina, Inc.
Invivoscribe, Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
Merck & Co., Inc.
Myriad Genetics, Inc.
Novartis AG
Pfizer Inc.
QIAGEN N.V.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	185
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 25.12 Billion
Forecasted Market Value ( USD ) by 2030	$ 47.11 Billion
Compound Annual Growth Rate	10.9%
Regions Covered	Global
No. of Companies Mentioned	27

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3377EUR$3,545USD£2,812GBP €3752EUR$3,939USD£3,124GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€5974EUR$6,272USD£4,974GBP €6638EUR$6,969USD£5,527GBP

Understanding Market Dynamics in the Next-Generation Breast Cancer Diagnostic & Screening Market

Exploring Porter’s Five Forces for the Next-Generation Breast Cancer Diagnostic & Screening Market

Applying PESTLE Analysis to the Next-Generation Breast Cancer Diagnostic & Screening Market

Analyzing Market Share in the Next-Generation Breast Cancer Diagnostic & Screening Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Next-Generation Breast Cancer Diagnostic & Screening Market

Strategic Recommendations for Success in the Next-Generation Breast Cancer Diagnostic & Screening Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Breast Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Global Breast Cancer Diagnostics Market by Technique (Imaging, Molecular Testing, Tissue Biopsy Tests), Cancer Type (BRCA Breast Cancer, EGFR Mutation Test Breast Cancer, ER & PR Breast Cancer), Component, Diagnostic Type, End-User - Forecast 2024-2030

Breast Cancer Diagnostics Global Market Report 2024

Next-Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F